Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Thursday 07 May, 2020

JP Morgan Sec LLC

AbbVie Inc. 38.5(b) Amendment

RNS Number : 2945M
J.P. Morgan Securities LLC
07 May 2020
 

Ap27

 

 

AMENDMENT

FORM   38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, 

OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

 

1.  KEY   INFORMATION

 

Nameofexemptprincipaltrader

J.P Morgan Securities LLC

Companydealtin

AbbVie Inc.

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 1)

Common stock

Date of dealing

5 May 2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   2)

 

 

Long

Short

 

Number

 

(%)

Number

 

(%)

10,633,169  0.72

 3,863,899  0.26

(2) Derivatives (other than options)

 5,749,563  0.39

 8,132,054  0.55

(3)Optionsandagreementstopurchase/sell

 767,000  0.05

 773,100  0.05

Total

17,149,732  1.16

 12,769,053  0.86

             

 

 

(b)  Interests and short positions in relevant securities of the company, other than the class dealt in  (Note   2)

 

Classofrelevantsecurity:

Long

Short

 

Number

 

(%)

Number

 

(%)

 

 

(2) Derivatives (other than options)

 

 

(3)Optionsandagreementstopurchase/sell

 

 

Total

 

 

             

 

Ap28

 

 

3.  DEALINGS  (Note   3)

 

(a)  Purchases and sales

 

Purchase/sale

Numberofrelevantsecurities

Priceperunit (Note 4)

Sale (Borrow Return)

 

Purchases

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

67,600

 

3

3

784

3

34

100

25

36

5

1,900

3

2

120

100

77

19

56

867

2,593

6

105

12

6,301

2

8

2

17

79

64

375

7,346

2,870

3,251

100

3

2,897

3,223

283

100

880

104

330

200

300

100

200

100

100

400

100

2,055

100

126

167

200

100

100

100

1,741

4,096

90

3,298

2,602

524

27

66

700

100

129

100

61

826

102

9

100

2

382

100

100

23

1,335

131

13,970

264

500

35

1,800

100

57

130

2,097

32

343

1,631

802

277

1,173

244

148

110

5,926

228

1,200

100

192

3,302

100

4,037

3,946

1,222

6,216

110

1,422

3

528

139

200

400

100

1

1,980

301

1,682

86

5,027

300

65

54

1,047

65

4,580

16

203

205

3,037

2,854

2,278

10,000

2,640

2,695

6

1,524

21

566

100

1,338

150

92

2,400

2,444

100

165

1,500

100

2,602

26

18

200

100

8

200

2,002

100

100

43

100

 

1,690

200

400

784

84

100

33

68

524

100

1,147

1,000

55

12,859

15,317

1,400

1,200

100

100

600

3

59

1,800

2,097

1

343

294

500

2

68

21

200

100

400

87

200

3

5

16

220

249

114

1

10,000

3

227

71

500

22

22

3

7

94

23

50

2,002

NA

 

84.2500 USD

84.4100 USD

84.4305 USD

84.4900 USD

84.5306 USD

84.5500 USD

84.5982 USD

84.6094 USD

84.6100 USD

84.6126 USD

84.6200 USD

84.6300 USD

84.6400 USD

84.6500 USD

84.6722 USD

84.6753 USD

84.6900 USD

84.7018 USD

84.7042 USD

84.7150 USD

84.7200 USD

84.7225 USD

84.7257 USD

84.7500 USD

84.7550 USD

84.7600 USD

84.7611 USD

84.7640 USD

84.7700 USD

84.7774 USD

84.7831 USD

84.7899 USD

84.8374 USD

84.8400 USD

84.8500 USD

84.8619 USD

84.9059 USD

84.9086 USD

84.9100 USD

84.9432 USD

84.9500 USD

84.9548 USD

84.9600 USD

84.9700 USD

84.9800 USD

84.9900 USD

85.0100 USD

85.0300 USD

85.0375 USD

85.0400 USD

85.0428 USD

85.0500 USD

85.0745 USD

85.0778 USD

85.0900 USD

85.1000 USD

85.1100 USD

85.1200 USD

85.1416 USD

85.1453 USD

85.1633 USD

85.1689 USD

85.2256 USD

85.2563 USD

85.2600 USD

85.2821 USD

85.2986 USD

85.3000 USD

85.3007 USD

85.3100 USD

85.3169 USD

85.3256 USD

85.3295 USD

85.3322 USD

85.3500 USD

85.3650 USD

85.3700 USD

85.4000 USD

85.4200 USD

85.4443 USD

85.4490 USD

85.4500 USD

85.4548 USD

85.4556 USD

85.4700 USD

85.4759 USD

85.4909 USD

85.5100 USD

85.5200 USD

85.5600 USD

85.5689 USD

85.5800 USD

85.6050 USD

85.6121 USD

85.6321 USD

85.6453 USD

85.6500 USD

85.6599 USD

85.6600 USD

85.6601 USD

85.6630 USD

85.6677 USD

85.6692 USD

85.6700 USD

85.6733 USD

85.6859 USD

85.6900 USD

85.7021 USD

85.7107 USD

85.7111 USD

85.7186 USD

85.7291 USD

85.7370 USD

85.7422 USD

85.7500 USD

85.7533 USD

85.7642 USD

85.7775 USD

85.8000 USD

85.8100 USD

85.8599 USD

85.8822 USD

85.8979 USD

85.9300 USD

85.9328 USD

85.9333 USD

85.9400 USD

85.9540 USD

85.9597 USD

85.9700 USD

85.9934 USD

86.0210 USD

86.0262 USD

86.0313 USD

86.0368 USD

86.0375 USD

86.0398 USD

86.0400 USD

86.0402 USD

86.0421 USD

86.0500 USD

86.0636 USD

86.0672 USD

86.0675 USD

86.0700 USD

86.0772 USD

86.0794 USD

86.0849 USD

86.1096 USD

86.1157 USD

86.1200 USD

86.1550 USD

86.1567 USD

86.1600 USD

86.1616 USD

86.1653 USD

86.1694 USD

86.1700 USD

86.1800 USD

86.2039 USD

86.2100 USD

86.2500 USD

86.2700 USD

86.3500 USD

86.3900 USD

86.4300 USD

 

82.9200 USD

84.3950 USD

84.4225 USD

84.4305 USD

84.4800 USD

84.5000 USD

84.7400 USD

84.7500 USD

85.2563 USD

85.3100 USD

85.3492 USD

85.3540 USD

85.3600 USD

85.3700 USD

85.3773 USD

85.3800 USD

85.3900 USD

85.4200 USD

85.4300 USD

85.4433 USD

85.4600 USD

85.4632 USD

85.4909 USD

85.5689 USD

85.5900 USD

85.6050 USD

85.6560 USD

85.7163 USD

85.7250 USD

85.7368 USD

85.7900 USD

85.8000 USD

85.8100 USD

85.8150 USD

85.8191 USD

85.8200 USD

85.8233 USD

85.8840 USD

85.8944 USD

85.9666 USD

85.9873 USD

85.9881 USD

86.0100 USD

86.0400 USD

86.0500 USD

86.0735 USD

86.0880 USD

86.0881 USD

86.0900 USD

86.1150 USD

86.1167 USD

86.1300 USD

86.2032 USD

86.2100 USD

86.2300 USD

86.2500 USD

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 5)

Numberofrelevantsecurities

(Note 6)

Priceperunit

(Note 4)

Equity Swaps

Long

 

 

Short

784

2,097

 

524

1,800

343

84.4305 USD

85.5689 USD

 

85.2563 USD

85.4909 USD

85.6050 USD

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing,   selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 4)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 4)

 

 

 

 

 

(d)  Other   dealings   (including   transactions   in   respect   of   new   securities)   (Note   3)

 

Nature of transaction

(Note 7)

Details

Price per unit

(if applicable) (Note 4)

 

 

 

 

Ap29

 

4.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and 

any   other   person   relating   to   the   voting   rights   of   any   relevant   securities   under   any   option   referred   to  

on   this   form   or   relating   to   the   voting   rights  or future acquisition or disposal of any relevant securities 

to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

Is a Supplemental Form 38.5(b) attached?  (Note   8)    YES

 

 

Dateofdisclosure

7 May 2020

Contactname

Alwyn Basch

Telephone number

020 7742 7407

Name of offeree/offeror with which connected

Allergan plc

Nature of connection (Note 9)

Financial Advisor to Allergan plc

 

 

 

Ap31

 

 

SUPPLEMENTAL   FORM   38.5(b)

 

 

 

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS   OF OPEN POSITIONS

 

(This   form   should   be   attached   to   Form   38.5(b))   OPEN POSITIONS  (Note   1)

 

Productname,

e.g. call option

Written orpurchased

Numberofrelevant securitiestowhichtheoptionorderivativerelates

Exercise price (Note 2)

Type, e.g.American,Europeanetc.

Expiry date

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

10,000

6,100

41,200

8,400

11,200

7,200

21,100

2,500

7,900

5,600

2,500

8,500

10,000

100,000

200

50,600

600

2,000

200

15,000

15,000

200

20,000

7,900

9,500

8,500

6,100

18,200

8,400

11,200

7,200

21,100

2,500

4,500

5,600

2,500

100

300

300

1,000

20,000

100

15,000

15,000

100

20,000

102,500

31,300

32,300

16,400

65,000

900

7,000

4,400

45,000

29,100

9,700

8,300

12,300

13,300

1,000

140,000

5,100

9,000

2,800

20,000

15,000

15,000

20,000

102,500

31,300

32,300

11,400

8,900

1,900

4,400

29,100

20,000

1,700

100,000

600

100

3,000

1,100

15,000

15,000

20,000

1,600

1,200

700

1,800

105.00

110.00

85.00

92.50

95.00

100.00

80.00

87.50

90.00

97.50

115.00

105.00

110.00

70.00

85.00

92.50

95.00

100.00

90.00

91.57

95.93

97.50

82.37

95.00

100.00

105.00

110.00

85.00

92.50

95.00

100.00

80.00

87.50

90.00

97.50

115.00

85.00

92.50

95.00

100.00

82.50

90.00

91.57

95.93

97.50

82.37

60.00

65.00

70.00

75.00

77.50

85.00

72.50

67.50

80.00

55.00

60.00

65.00

70.00

75.00

77.50

82.50

62.50

72.50

67.50

80.00

78.49

82.85

78.35

60.00

65.00

70.00

75.00

77.50

72.50

67.50

55.00

60.00

65.00

70.00

75.00

77.50

72.50

67.50

78.49

82.85

78.35

75.00

77.50

72.50

80.00

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

18SEP20

18SEP20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

18SEP20

18SEP20

18SEP20

18SEP20

 

 

 

 

Notes

 

1.  Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.  For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rules 8 and

38.5 of the Rules. If in doubt, consult the Panel.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEBGGDUBSGDGGR

a d v e r t i s e m e n t